News for 'Elder Pharma'

Elder Pharma to hire 1,000 for rural sales

Elder Pharma to hire 1,000 for rural sales

Rediff.com15 Apr 2010

Elder Pharma employs about 3,300 people in India, with about 2,700 professionals in marketing and sales. This recruitment will help Elder Pharma to have one of the largest drug sales force in India, like market leaders such as Cipla, Ranbaxy, Piramal Healthcare and Lupin.

Seniors to Drive 25% of India's Pharma

Seniors to Drive 25% of India's Pharma

Rediff.com21 Nov 2025

'Once the 60-plus population hits 20 to 30 per cent of the country, the demand for elderly-care treatments will surge -- cardiac, metabolic, neurological, and musculoskeletal medicines are going to dominate the market for the next several decades.'

Elder Pharma eyes European firm

Elder Pharma eyes European firm

Rediff.com20 Nov 2006

Elder Pharmaceuticals, one of the fast growing pharmaceutical formulation company, is getting ready to make its maiden overseas acquisition.

Elder Pharma, US's Blistex in pact

Elder Pharma, US's Blistex in pact

Rediff.com6 Jun 2003

Elder Pharmaceuticals Ltd has entered into an alliance with US-based Blistex Inc to manufacture and introduce the latter's entire range of lip care products in India.\n\n\n\n

Cymbiotics, Elder Pharma sign 3 drug deal

Cymbiotics, Elder Pharma sign 3 drug deal

Rediff.com29 May 2007

Cymbiotics, a US-based bio-pharmaceutical manufacturer, has entered into a joint in-licensing agreement with Elder Pharmaceuticals to manufacture and market three of its drugs for pain management, diabetes and dermatology in the Indian market.

Budget 2026 boosts healthcare spend, drugs relief

Budget 2026 boosts healthcare spend, drugs relief

Rediff.com1 Feb 2026

The government on Sunday gave a strong push to upgradation and expansion of healthcare infrastructure, medical education and pharma sector with the Union Budget 2026-27 announcing a slew of steps, including those aimed at making India a global hub for allied healthcare professionals and biopharma manufacturing.

Russia strikes Indian pharma warehouse in Ukraine

Russia strikes Indian pharma warehouse in Ukraine

Rediff.com13 Apr 2025

A Russian missile struck a warehouse belonging to an Indian pharmaceutical company, Kusum, in Ukraine, according to the Ukrainian embassy in India. The embassy alleged that Russia, despite claiming a "special friendship" with India, deliberately targeted Indian businesses in Ukraine. The strike reportedly destroyed medicines intended for children and the elderly. This incident follows a similar attack on a major pharmaceuticals warehouse in Kyiv, which was destroyed by Russian drones, as reported by the UK's ambassador to Ukraine. Kusum Healthcare, the company whose warehouse was hit, has a presence in 29 countries, including Ukraine. This attack comes amidst ongoing tensions in the region as Russia continues its offensive against Ukraine, despite US efforts to push for a ceasefire. Ukrainian Foreign Minister Andrii Sybiha accused Russia of being the sole obstacle to peace and claimed that Moscow rejected a US-brokered proposal for a ceasefire.

Roche inks marketing pact with Elder

Roche inks marketing pact with Elder

Rediff.com15 Dec 2006

Swiss-based pharma multinational Roche Scientific has finalised a marketing agreement with Elder Pharmaceuticals to sell its new post-menopausal osteoporosis drug, Bonviva, in the country.

Interesting pharma picks for your portfolio

Interesting pharma picks for your portfolio

Rediff.com23 Oct 2006

Surya Narayan Patra of SSKI & Sharekhan discusses his picks from the pharma space

Street concerns at Torrent-Elder deal

Street concerns at Torrent-Elder deal

Rediff.com16 Dec 2013

Analysts are divided on the deal valuations. Some say Torrent could have bargained harder, as Sanofi, among others, passed it over.

Indemnity demands from pharma firms hit foreign Covid vaccine buy: Mandaviya

Indemnity demands from pharma firms hit foreign Covid vaccine buy: Mandaviya

Rediff.com25 Jun 2023

He also said that it was wrong to suggest that India stopped foreign made vaccines like that made by Moderna and Pfizer from coming to India.

Goodbye Skipper!

Goodbye Skipper!

Rediff.com29 Nov 2024

'He asserted in his usual jovial style that he was not an MBA like his audience at IIM-Ahmedabad but perhaps had an even better business degree: MBB'. 'He went on to explain to his perplexed, blue chip B-School audience that MBB stood for "Marwadi by birth"!' Shivanand Kanavi salutes Shashi Ruia, co-founder of the Essar group who passed into the ages on November 25, 2024 in Mumbai.

Misleading ads: ASCI pulls up Reliance, Idea

Misleading ads: ASCI pulls up Reliance, Idea

Rediff.com28 Dec 2009

During the said period, the Consumer Complaints Council of ASCI found 15 advertisers, including Reliance Communications and Idea Cellular, fast moving consumer goods player Dabur and Elder Pharma and coaching centre Career Launcher, violating the council's code.

Gen-next boost to Cipla's growth pill

Gen-next boost to Cipla's growth pill

Rediff.com14 Sep 2011

Samina Vaziralli, daughter of joint Managing Director M K Hamied, was inducted into the company management. Cipla joins the league of major companies such as Lupin, Wockhardt, Elder Pharma, Piramal Healthcare and JB Chemicals in this regard.

Indian pharma's Trump fears

Indian pharma's Trump fears

Rediff.com1 Feb 2017

Industry fears tougher US stance on IP after President Donald Trump asserted that foreign countries must pay a fair share for drug development costs. Aneesh Phadnis reports.

Sun gets US trade regulator nod for Ranbaxy merger

Sun gets US trade regulator nod for Ranbaxy merger

Rediff.com1 Feb 2015

Torrent to buy Ranbaxy's anti-bacterial generic

Centre advises use of mask in crowded areas amid fresh Covid scare

Centre advises use of mask in crowded areas amid fresh Covid scare

Rediff.com21 Dec 2022

He urged people not to panic and clarified that there was no change in the guidelines for international air travel so far.

Pharma firms spend 10% of production cost on tie-ups

Pharma firms spend 10% of production cost on tie-ups

Rediff.com20 Aug 2012

This helps consumers check the authenticity of drugs simply by sending SMSes.

Carlyle in talks to buy 28% stake in Trehan's hospital

Carlyle in talks to buy 28% stake in Trehan's hospital

Rediff.com22 Aug 2013

Global private equity (PE) major Carlyle is in talks with renowned cardiac surgeon Dr Naresh Trehan to acquire a minority stake in his Gurgaon-based multi-super speciality hospital, Medanta -The Medicity.

Govt panel recommends regular market approval for Covishield, Covaxin

Govt panel recommends regular market approval for Covishield, Covaxin

Rediff.com20 Jan 2022

An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to COVID vaccines Covishield and Covaxin for use in adult population subject to certain conditions, official sources said.

Succession is a lesson even Buffett hasn't learnt

Succession is a lesson even Buffett hasn't learnt

Rediff.com3 May 2016

It is almost puzzling to see more old men and women hang around long enough for people to begin wondering 'why not retire?'

More companies should be allowed to produce vaccines: Gadkari

More companies should be allowed to produce vaccines: Gadkari

Rediff.com19 May 2021

Union Minister Nitin Gadkari on Tuesday said that more pharma companies should be allowed to manufacture the COVID-19 vaccine in the country during the pandemic to scale up production.

Modi, WHO chief lay the ground for traditional medicine centre in Jamnagar

Modi, WHO chief lay the ground for traditional medicine centre in Jamnagar

Rediff.com19 Apr 2022

Prime Minister Narendra Modi on Tuesday said the establishment of the WHO Global Centre for Traditional Medicine (WHO GCTM) in Jamnagar will usher in a new era of traditional medicine globally.

Company FDs require extra due diligence

Company FDs require extra due diligence

Rediff.com25 Mar 2016

Keep regular track of financials, including cash flow and management changes

Twitter deliberately chose path of non-compliance: Prasad

Twitter deliberately chose path of non-compliance: Prasad

Rediff.com16 Jun 2021

Lashing out at the micro-blogging platform over non-compliance, Prasad said that it is "astounding" that Twitter that portrays itself as the flag bearer of free speech, chooses the path of deliberate defiance when it comes to the intermediary guidelines.

'MF Guru, I know I messed a bit'

'MF Guru, I know I messed a bit'

Rediff.com4 Nov 2022

Omkeshwar Singh, Head, Rank MF, a mutual fund investment platform, answers your queries.

Urge states to use lockdown as last resort, PM Modi tells nation

Urge states to use lockdown as last resort, PM Modi tells nation

Rediff.com20 Apr 2021

The two key messages of Modi's over 20 minute-long address was, however, to virtually rule out any immediate nationwide lockdown, a move that had triggered a massive migration of workers from big cities last year and hit the economy hard, and to reach out to migrants.

Twitter deliberately chose path of non-compliance: Prasad

Twitter deliberately chose path of non-compliance: Prasad

Rediff.com16 Jun 2021

IT minister Ravi Shankar Prasad on Wednesday slammed Twitter for deliberate defiance and failure to comply with the country's new IT rules, which has led to the United States giant losing its intermediary status in India and becoming liable for users posting any unlawful content.

For advertisers, old is now gold

For advertisers, old is now gold

Rediff.com25 Sep 2017

60-plus men and women who live independent lives are becoming the cynosure of ad men's eyes.

Lessons from the Fortis/Raymond family feuds

Lessons from the Fortis/Raymond family feuds

Rediff.com7 Jan 2019

'Nothing in this world is permanent. So also in business.' 'And more so in family businesses where family issues often influence business decisions,' point out S Subramanian and Nupur Pavan Bang.

Serum Institute's race to produce COVID-19 vaccine

Serum Institute's race to produce COVID-19 vaccine

Rediff.com23 May 2020

'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'